External Defibrillators Market Size, Share & Trends Analysis Report By Product (Manual External Defibrillators, Wearable Cardioverter Defibrillators), By End-use (Hospital, Pre Hospital), By Region, And Segment Forecasts, 2024 - 2030

External Defibrillators Market Size & Trends

The global external defibrillators market size was estimated at USD 3.51 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.7% from 2024 to 2030. Increasing technological advancements, government initiatives for the installation of AEDs in public places, incidence of sudden cardiac arrest, and initiatives by key market players are some of the key drivers of this market growth. According to the American College of Cardiology Foundation in March 2021, the availability of public access to Automated External Defibrillators (AEDs) has significantly impacted the survival rates of sudden cardiac arrests. The elevated risk of various heart conditions within the target population presents numerous opportunities for AEDs, particularly the development and utilization of at-home AEDs, to mitigate the risk of cardiac arrest among diverse populations.

The COVID-19 pandemic significantly boosted the demand for external defibrillators despite the supply chain challenges and other hurdles brought by movement restrictions. Nihon Kohden for instance, reported double-digit growth in international sales in 2020 (including the U.S. and Latin America) due to the increased demand during the COVID-19 pandemic. Sales in Mexico and Colombia recorded 200% growth due to a surge in demand for Nihon Kohden’s patient monitors, defibrillators, and ventilators. In June 2020, Philips received FDA clearance for HeartStart FRx and HeartStart FR3 automated external defibrillators. HeartStart FR3 includes innovative features to help medical personnel and first responders treat cardiac arrest. HeartStart FRx is a public-access automated external defibrillator that features intuitive, step-by-step voice instructions, comprising cardiopulmonary resuscitation guidance, for emergency use in schools, workplaces, and other public spaces, in addition to medical professional use.

The increasing number of supportive policies by governments, regulatory bodies, and healthcare organizations is anticipated to fuel the market growth over the forecast period. For example, the IRC (Italian Resuscitation Council) reported that the proposed law on AEDs in Italy was approved by the Social Affairs Commission of the Chamber in July 2021. The law provides for about 10 million EUR (about USD 11.36 million) for implementing public access AEDs over the next five years, among other provisions. In Australia, the government agency SA Ambulance Service (SAAS), recommends the use of a defibrillator as early as possible to increase the person’s chances of survival. Both semiautomatic and automatic AEDs are recommended, while manual defibrillators are recommended for use by trained professionals only. Due to their ease of use, AEDs are also recommended over a manual defibrillator in low acuity settings, including medical clinics and allied health and dental clinics.

Market Dynamics

The growing population of cardiac patients due to the sedentary lifestyle in the global population, coupled with the expanding geriatric demographic, has led to an uptick in the prevalence of cardiac diseases. Consequently, there has been a surge in hospital admissions, particularly in critical care units. A press release from Boehringer Ingelheim GmbH in August 2021 revealed that the chronic and debilitating cardio-renal-metabolic condition, heart failure, affects nearly 60 million or more individuals worldwide. In addition, data released by the Australian Institute of Health and Welfare in May 2022 indicated that out of 11.8 million hospital admissions, 7% involved stays in the intensive care unit, with 3.8% of admissions attributed to cardiovascular diseases (CVDs). The increasing admissions to emergency and critical care settings underscore the necessity for the availability of cardiac rhythm management devices, thereby creating opportunities for external defibrillators and contributing to the market's overall growth.

Furthermore, technological advancements have made modern external defibrillators more compact, user-friendly, and require less maintenance, contributing to increased cost-effectiveness. In the U.S., the pricing for AEDs typically ranges between USD 900 and 2,000. AED USA, for instance, offers the Zoll AED Plus Fully Automatic defibrillators at USD 1,699 and the ZOLL AED three semi-automatic at USD 1,895. According to the World Health Organization (WHO), manual external defibrillators are priced between USD 1,000 and 25,000. Noteworthy technology trends in the market include advancements in personal AEDs designed for home use, integration of drones to enhance response to cardiac arrests, solutions aimed at improving the tracking of AEDs, and the utilization of the Internet of Things (IoT) and analytics. Australia-based Rapid Response Revival Research Ltd has notably developed the world's first personal AED, CellAED, designed for home use. It received CE Certification in May 2021, facilitating its commercialization across Europe.

Product Insights

The manual external defibrillators segment dominated the market in 2023 with the largest revenue share of more than 39.58% in 2023. This growth is primarily propelled by advancements in technology, which have enhanced the effectiveness and versatility of manual external defibrillators. These devices, operated by healthcare professionals or trained personnel, offer precise control over defibrillation, allowing for tailored interventions based on the patient's specific cardiac rhythm. Hospitals, clinics, and emergency medical services increasingly incorporate these devices into their critical care protocols, emphasizing their crucial role in improving patient outcomes during cardiac emergencies.

The AEDs segment is estimated to witness the fastest CAGR over the forecast period. This is because of growing initiatives by major companies, increasing adoption of defibrillators at healthcare facilities, and deployment of several public access defibrillation programs. For instance, in September 2021, Stryker Corporation and U.S. Lacrosse established a partnership, designating Stryker Corporation as the Official AED provider for U.S. Lacrosse and the U.S. National Teams. Under this collaboration, members of U.S. Lacrosse were offered discounted rates on Stryker AED devices. These strategic initiatives are poised to be instrumental in propelling segment market growth.

End-use Insights

Based on end-use, the hospital segment held the largest revenue share of over 26.01% in 2023. This is attributable to a higher volume of patients received in hospitals, growing adoption of external defibrillators by hospitals, and strategies implemented by key manufacturers. The cardiology units in the hospitals require defibrillators to manage patients facing cardiac-related problems. The rising incidence of hypertension, diabetes, and strokes leading to SCA due to lack of physical activity, unhealthy dietary habits, and smoking is likely to drive demand for defibrillators in hospitals. For instance,as per the Arrhythmia Alliance Report, 2023, approximately 1 in 50 Americans under the age of 65 and 1 in 10 Americans over the age of 65 are afflicted by atrial fibrillation on an annual basis. In addition, an estimated 1 in 2,100 individuals experience ventricular arrhythmias annually in the U.S. This notable prevalence of arrhythmia is expected to generate heightened demand for external defibrillators, thereby catalyzing driving market growth.

The public access segment is projected to witness the fastest CAGR over the forecast period owing to supportive initiatives by governments, regulatory agencies, and healthcare institutions to increase the availability of public access AEDs.The Automated External Defibrillators (Public Access) Bill was introduced in the House of Commons of the UK Parliament in June 2021. If the bill receives royal assent, it would become mandatory to install defibrillators at public places such as sporting facilities, schools, skills facilities, buildings, and facilities that provide care to vulnerable people.

Regional Insights

North America held a revenue share of more than 42.93% in 2023. The large share of the North American region can be attributed to the presence of key players, supportive regulations to increase the availability of public access AEDs, and high adoption of external defibrillators at healthcare facilities.Many national organizations in the U.S., including the American Heart Association (AHA), recommend implementing comprehensive Public Access Defibrillation (PAD) programs. The suggested attributes for such a program include targeted placement of AEDs (including their routine maintenance and testing), imparting training to responders, Emergency Medical Services (EMS) coordination, and continuous quality improvement.

Europe is estimated to witness the fastest CAGR of 10.6% in the external defibrillators industry over the next few years. This is owing to well-established healthcare infrastructure, large geriatric population susceptible to CVD adverse events, and local presence of key companies. For instance, WEINMANN Emergency Medical Technology GmbH + Co. KG is a German manufacturer that offers the MEDUCORE Standard series of external defibrillators for resuscitation and patient monitoring. The series is intended to be used by emergency medical services personnel, military medical corps, and hospitals.

Key Companies & Market Share Insights

The market for external defibrillators is competitive in nature. The market is highly fragmented, owing to the presence of several small as well as large players. This results in high competition among smaller players looking to sustain their position in the market. Moreover, companies are increasingly adopting strategies such as mergers and acquisitions, geographic expansion, and launch of new products to grow in the market. For instance, In September 2021, ZOLL MEDICAL made a strategic move by introducing three models of AEDs to enter the Thailand market. The company anticipated a surge in demand for AEDs in Thailand, estimating the requirement to reach 10,000 units. This initiative by ZOLL MEDICAL reflects a proactive step to address the growing need for AEDs in the Thai market, showcasing a commitment to meet the region's demand for life-saving defibrillation technology.

External Defibrillators Market Report Scope

Global External Defibrillators Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global external defibrillators market report based on product, end-use, and region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Manual External Defibrillators

  • Automated External Defibrillators

    • Semi-Automated ED

    • Fully Automated ED

  • Wearable Cardioverter Defibrillators

• End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospital

  • Pre Hospital

  • Public Access Market

  • Alternate Care Market

  • Home Healthcare

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

  • U.S.

  • Canada

  • Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

  • Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

  • Latin America

  • Brazil

  • Mexico

  • Argentina

  • Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait